On the morning of September 29, 2015, Wu Zhen, Vice Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Robert Holleyman, Deputy United States Trade Representative. Both sides exchanged opinions on the latest progress of China’s reform of drug evaluation and approval system, and issues of common concerns on this year's 26th session of the China-U.S. Joint Commission on Commerce and Trade (JCCT). Relevant directors of CFDA's Department of International Cooperation, Department of Drug and Cosmetics Registration and Department of Medical Device Registration attended the meeting.